NSUN2 stimulates tumor progression via enhancing TIAM2 mRNA stability in pancreatic cancer

[1]  F. Dong,et al.  NSUN2-mediated RNA m5C modification modulates uveal melanoma cell proliferation and migration , 2022, Epigenetics.

[2]  Holger Knaut,et al.  Focal adhesion-mediated cell anchoring and migration: from in vitro to in vivo. , 2022, Development.

[3]  Peng-Chieh Chen,et al.  RNA bisulfite sequencing reveals NSUN2-mediated suppression of epithelial differentiation in pancreatic cancer , 2022, Oncogene.

[4]  Mariana Cooke.  Novel insights into the RTK-dependent metastatic phenotype of KRAS-mutant lung adenocarcinoma , 2021, Molecular & Cellular Oncology.

[5]  M. Kazanietz,et al.  FARP1, ARHGEF39, and TIAM2 are essential receptor tyrosine kinase effectors for Rac1-dependent cell motility in human lung adenocarcinoma. , 2021, Cell reports.

[6]  Libing Wang,et al.  m5C RNA methyltransferase-related gene NSUN4 stimulates malignant progression of hepatocellular carcinoma and can be a prognostic marker. , 2021, Cancer biomarkers : section A of Disease markers.

[7]  Y. Hu,et al.  NSUN2 modified by SUMO-2/3 promotes gastric cancer progression and regulates mRNA m5C methylation , 2021, Cell Death & Disease.

[8]  D. Lin,et al.  NSUN2-mediated RNA 5-methylcytosine promotes esophageal squamous cell carcinoma progression via LIN28B-dependent GRB2 mRNA stabilization , 2021, Oncogene.

[9]  Xiaoting Lin,et al.  lncRNA ITGB8-AS1 functions as a ceRNA to promote colorectal cancer growth and migration through integrin-mediated focal adhesion signaling , 2021, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  Huaizhi Wang,et al.  N6-methyladenosine (m6A) in pancreatic cancer: Regulatory mechanisms and future direction , 2021, International journal of biological sciences.

[11]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[12]  S. Blanco,et al.  The role of m6A, m5C and Ψ RNA modifications in cancer: Novel therapeutic opportunities , 2021, Molecular Cancer.

[13]  Yu-Sheng Chen,et al.  Dynamic transcriptomic m5C and its regulatory role in RNA processing , 2021, Wiley interdisciplinary reviews. RNA.

[14]  Chengxi Liu,et al.  Elevated TIAM2 expression promotes tumor progression and is associated with unfavorable prognosis in pancreatic cancer , 2020, Scandinavian journal of gastroenterology.

[15]  R. Kohli,et al.  TET-mediated 5-methylcytosine oxidation in tRNA promotes translation , 2020, The Journal of biological chemistry.

[16]  Xin Xu,et al.  NSun2 promotes cell migration through methylating autotaxin mRNA , 2020, The Journal of Biological Chemistry.

[17]  H. Cui,et al.  Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma , 2020, Oncogene.

[18]  J. T. Tseng,et al.  TIAM2S Mediates Serotonin Homeostasis and Provokes a Pro-Inflammatory Immune Microenvironment Permissive for Colorectal Tumorigenesis , 2020, Cancers.

[19]  Yun Feng,et al.  RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner , 2020, Molecular Cancer.

[20]  Jiang Chang,et al.  N6-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression , 2020, Gut.

[21]  T. Kouzarides,et al.  Role of RNA modifications in cancer , 2020, Nature Reviews Cancer.

[22]  Ming-Hai Wang,et al.  RNA methyltransferase NSUN2 promotes gastric cancer cell proliferation by repressing p57Kip2 by an m5C-dependent manner , 2020, Cell Death & Disease.

[23]  Heshui Wu,et al.  Overexpression of YBX1 Promotes Pancreatic Ductal Adenocarcinoma Growth via the GSK3B/Cyclin D1/Cyclin E1 Pathway , 2020, Molecular therapy oncolytics.

[24]  T. Preiss,et al.  Multiple links between 5-methylcytosine content of mRNA and translation , 2020, BMC Biology.

[25]  Shikui Tu,et al.  Integrated analysis of transcriptome-wide m6A methylome of osteosarcoma stem cells enriched by chemotherapy. , 2019, Epigenomics.

[26]  T. H. Nguyen,et al.  The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.

[27]  Zheng Wang,et al.  NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma , 2019, Cancer science.

[28]  Jun Xia,et al.  RNA 5-Methylcytosine Facilitates the Maternal-to-Zygotic Transition by Preventing Maternal mRNA Decay. , 2019, Molecular cell.

[29]  R. Sun,et al.  N6-methyladenosine-related Genomic Targets are Altered in Breast Cancer Tissue and Associated with Poor Survival , 2019, Journal of Cancer.

[30]  Dan Xie,et al.  5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs , 2019, Nature Cell Biology.

[31]  H. Cui,et al.  Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells. , 2019, Epigenomics.

[32]  M. Bohnsack,et al.  Eukaryotic 5-methylcytosine (m5C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease , 2019, Genes.

[33]  P. Gallo,et al.  Promoting genetics in non-alcoholic fatty liver disease: Combined risk score through polymorphisms and clinical variables , 2018, World journal of gastroenterology.

[34]  K. Hahn,et al.  STEF/TIAM2-mediated Rac1 activity at the nuclear envelope regulates the perinuclear actin cap , 2018, Nature Communications.

[35]  N. Gray,et al.  Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. , 2017, Blood.

[36]  Samir Adhikari,et al.  5-methylcytosine promotes mRNA export — NSUN2 as the methyltransferase and ALYREF as an m5C reader , 2017, Cell Research.

[37]  T. N. Gaitanos,et al.  Tiam–Rac signaling mediates trans-endocytosis of ephrin receptor EphB2 and is important for cell repulsion , 2016, The Journal of cell biology.

[38]  Steven L Salzberg,et al.  HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.

[39]  Tsonwin Hai,et al.  PHAGOCYTES, GRANULOCYTES, AND MYELOPOIESIS ATF3 is a novel regulator of mouse neutrophil migration , 2016 .

[40]  Juntao Liu,et al.  TIAM2 enhances non-small cell lung cancer cell invasion and motility. , 2013, Asian Pacific journal of cancer prevention : APJCP.

[41]  E. Nestler,et al.  diffReps: Detecting Differential Chromatin Modification Sites from ChIP-seq Data with Biological Replicates , 2013, PloS one.

[42]  M. Tatsuka,et al.  Frequent increased gene copy number and high protein expression of tRNA (cytosine-5-)-methyltransferase (NSUN2) in human cancers. , 2012, DNA and cell biology.

[43]  Kung-Chia Young,et al.  Expression of T‐cell lymphoma invasion and metastasis 2 (TIAM2) promotes proliferation and invasion of liver cancer , 2012, International journal of cancer.

[44]  Chuan He,et al.  Tet Proteins Can Convert 5-Methylcytosine to 5-Formylcytosine and 5-Carboxylcytosine , 2011, Science.

[45]  A. Malliri,et al.  The Rac activator STEF (Tiam2) regulates cell migration by microtubule‐mediated focal adhesion disassembly , 2010, EMBO reports.

[46]  Clifford A. Meyer,et al.  Model-based Analysis of ChIP-Seq (MACS) , 2008, Genome Biology.

[47]  F. Watt,et al.  The RNA Methyltransferase Misu (NSun2) Mediates Myc-Induced Proliferation and Is Upregulated in Tumors , 2006, Current Biology.

[48]  E. Kim,et al.  Cloning and characterization of T-cell lymphoma invasion and metastasis 2 (TIAM2), a novel guanine nucleotide exchange factor related to TIAM1. , 1999, Genomics.